MRD / Regn No. : TL//20-21//01024 Date : 19/06/2026
Patient Name : Anukriti Goyal Age & Gender : 28 Yrs. / Female
Contact No. : 9769837375 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Subjective : DIAGNOSED PRIMARY HYPOTHYROIDISM,OCD,MOTHER PCOS,DIAGNOSED ADHD,DID NOT TOLERATE OR HAVE ANY RESULT WITH ORLISTAT,DIET + THYROID OPTIMISATION + LSM (GYM) - SEE FOR WEIGHT TRAJECTORY,MAY ADD METFORMIN
Objective : APRIL 25- T3- 1.21/T4- 14.6/TSH- 20.017,JUNE 26,T3-0.91/T4-8.4/TSH-3.93,VIT B12-268
Plan : 137+25 TILL HAS STOCK OF 137 - AFTER THAT MAKE IT 150 MCG DAILY,ORAL SEMAGLUTIDE ( RYBELSUS) / INJ TIRZEPATIDE (MOUNJARO)  
S# Generic (Trade) Name Route Dosage Usage Duration
1 NERVIHENZ PLUS ORAL 0-1-0 AFTER LUNCH / 3 DAYS A WEEK
 TO CONTINUE
2 DRISE 60,000 UNITS ORAL ONCE IN 15 DAYS ANYTIME OF DAY
 TO CONTINUE
3 TABLET ETHINYL ESTRADIOL 30 MCG LEVONORGESTREL 0.15 MG
OVRAL L 		PO 0-0-1 AD
 21 DAYS EVERY CYCLE X 12 MTHS
4 TABLET THYROXINE SODIUM 150 MCG
THYRONORM 150 MCG 		ORAL 1-0-0 BBF
 4 MTHS
5 TABLET METFORMIN 500MG
CETAPIN XR 500 MG 		ORAL 1-0-1 ABF / AD
 4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 09/Aug/2025
Tests Suggested For Next Visit : TOTAL T3 / T4 / TSH > 30 DAYS AND THEN AFTER 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: